Product
VARIVAX
1 clinical trial
1 indication
Indication
ChickenpoxClinical trial
A Double-blind, Randomized, Multi-Center, Active Controlled Phase 2 Clinical Trial to Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella VaccinationStatus: Recruiting, Estimated PCD: 2025-06-01